Searched over 200M research papers
10 papers analyzed
These studies suggest that high blood pressure and high cholesterol levels are interrelated and significantly increase the risk of coronary heart disease, necessitating lifestyle changes and interventions to reduce cardiovascular events.
20 papers analyzed
High blood pressure (BP) and elevated cholesterol levels are two of the most significant risk factors for cardiovascular diseases (CVD), including coronary heart disease (CHD) and stroke. These conditions often coexist and can synergistically increase the risk of adverse cardiovascular events.
Research indicates that the combination of high BP and elevated total cholesterol significantly increases the lifetime risk (LTR) of CHD mortality. A study involving 105,432 Japanese participants found that individuals with both high BP and high total cholesterol levels had a markedly increased LTR of CHD mortality. Specifically, men and women with grade 2-3 hypertension and high total cholesterol levels had LTRs of 7.73% and 5.77%, respectively, compared to those with normal BP and lower cholesterol levels.
The combined effect of high BP and elevated cholesterol on cardiovascular mortality has been extensively studied. A meta-analysis of 73,916 Japanese subjects revealed that individuals with systolic BP ≥160 mm Hg and total cholesterol ≥5.7 mmol/L had the highest risk for CHD death. The study also found that the risk of CHD death increased with higher levels of both BP and cholesterol, demonstrating a synergistic effect. This synergy was not observed for stroke, where BP and cholesterol acted independently.
The relationship between high-density lipoprotein cholesterol (HDL-C) and BP is complex. A large-scale study of 1,493,152 Japanese individuals found a U-shaped relationship between HDL-C levels and BP, indicating that both low and extremely high HDL-C concentrations are associated with high BP. This relationship persisted even after adjusting for confounding factors such as body mass index and serum triglyceride levels. Another study from Korea confirmed that lower HDL-C levels are associated with higher BP, particularly systolic BP, in both men and women.
Recent data from the United States show that while there have been improvements in serum lipid concentrations among children and adolescents, BP levels have remained stable or increased. Approximately 20.2% of youths had adverse lipid concentrations, and 11.0% had either high or borderline high BP. These trends highlight the need for early intervention to manage both cholesterol and BP from a young age.
Interventions to lower systolic BP and cholesterol are not only effective but also cost-efficient. Global analyses suggest that non-personal health interventions, such as reducing the salt content in processed foods, can significantly reduce the incidence of cardiovascular events. Combination treatments for individuals at high risk of cardiovascular events can avert millions of disability-adjusted life years (DALYs) annually, demonstrating the substantial health benefits of managing these risk factors.
The interplay between high BP and elevated cholesterol significantly increases the risk of cardiovascular diseases, particularly CHD. Both conditions should be managed concurrently to reduce the overall risk of cardiovascular mortality. Early intervention, lifestyle changes, and cost-effective public health strategies are essential to mitigate these risks and improve cardiovascular health outcomes globally.
Most relevant research papers on this topic